Urologix, Inc. (ULGX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2013 | -6.93 Million USD | -76.7% |
| 2012 | -3.92 Million USD | 5.38% |
| 2011 | -4.14 Million USD | -11.25% |
| 2010 | -3.72 Million USD | -65.09% |
| 2009 | -2.25 Million USD | 49.45% |
| 2008 | -4.46 Million USD | 73.42% |
| 2007 | -16.79 Million USD | -88.07% |
| 2006 | -8.93 Million USD | -1261.51% |
| 2005 | 769 Thousand USD | -75.38% |
| 2004 | 3.12 Million USD | 433.85% |
| 2003 | 585 Thousand USD | 105.75% |
| 2002 | -10.17 Million USD | -439.58% |
| 2001 | -1.88 Million USD | 67.95% |
| 2000 | -5.88 Million USD | 31.41% |
| 1999 | -8.57 Million USD | 45.73% |
| 1998 | -15.8 Million USD | -14.49% |
| 1997 | -13.8 Million USD | -38.0% |
| 1996 | -10 Million USD | -28.21% |
| 1995 | -7.8 Million USD | -34.48% |
| 1994 | -5.8 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2014 Q2 | -134 Thousand USD | 44.4% |
| 2014 Q1 | -241 Thousand USD | 92.93% |
| 2014 Q3 | -153 Thousand USD | -14.18% |
| 2013 Q3 | -1.46 Million USD | -64.46% |
| 2013 Q4 | -3.4 Million USD | -132.31% |
| 2013 FY | -6.93 Million USD | -76.7% |
| 2013 Q1 | -1.16 Million USD | 9.36% |
| 2013 Q2 | -892 Thousand USD | 23.24% |
| 2012 Q1 | -926 Thousand USD | 14.73% |
| 2012 FY | -3.92 Million USD | 5.38% |
| 2012 Q2 | -829 Thousand USD | 10.48% |
| 2012 Q4 | -1.28 Million USD | -45.02% |
| 2012 Q3 | -884 Thousand USD | -6.63% |
| 2011 Q4 | -1.08 Million USD | -29.29% |
| 2011 Q2 | -900 Thousand USD | 31.97% |
| 2011 Q1 | -1.32 Million USD | -0.53% |
| 2011 FY | -4.14 Million USD | -11.25% |
| 2011 Q3 | -840 Thousand USD | 6.67% |
| 2010 FY | -3.72 Million USD | -65.09% |
| 2010 Q4 | -1.31 Million USD | -33.47% |
| 2010 Q3 | -986 Thousand USD | -36.75% |
| 2010 Q2 | -721 Thousand USD | -2.56% |
| 2010 Q1 | -703 Thousand USD | -0.86% |
| 2009 Q3 | -598 Thousand USD | -112.06% |
| 2009 FY | -2.25 Million USD | 49.45% |
| 2009 Q4 | -697 Thousand USD | -16.56% |
| 2009 Q2 | -282 Thousand USD | 58.59% |
| 2009 Q1 | -681 Thousand USD | 25.74% |
| 2008 Q2 | -1.06 Million USD | 17.42% |
| 2008 FY | -4.46 Million USD | 73.42% |
| 2008 Q4 | -917 Thousand USD | 23.52% |
| 2008 Q1 | -1.28 Million USD | 43.92% |
| 2008 Q3 | -1.19 Million USD | -12.9% |
| 2007 Q4 | -2.29 Million USD | -3.15% |
| 2007 Q3 | -2.22 Million USD | 81.19% |
| 2007 Q1 | -466 Thousand USD | 93.72% |
| 2007 Q2 | -11.81 Million USD | -2435.62% |
| 2007 FY | -16.79 Million USD | -88.07% |
| 2006 FY | -8.93 Million USD | -1261.51% |
| 2006 Q4 | -7.42 Million USD | -707.51% |
| 2006 Q3 | -919 Thousand USD | -1535.94% |
| 2006 Q2 | 64 Thousand USD | 109.77% |
| 2006 Q1 | -655 Thousand USD | -1623.68% |
| 2005 Q2 | 305 Thousand USD | 160.68% |
| 2005 Q1 | 117 Thousand USD | -84.52% |
| 2005 FY | 769 Thousand USD | -75.38% |
| 2005 Q3 | 385 Thousand USD | 26.23% |
| 2005 Q4 | -38 Thousand USD | -109.87% |
| 2004 Q2 | 804 Thousand USD | 0.12% |
| 2004 Q1 | 803 Thousand USD | -1.35% |
| 2004 Q4 | 756 Thousand USD | -0.53% |
| 2004 FY | 3.12 Million USD | 433.85% |
| 2004 Q3 | 760 Thousand USD | -5.47% |
| 2003 FY | 585 Thousand USD | 105.75% |
| 2003 Q1 | -496 Thousand USD | 86.75% |
| 2003 Q2 | -214 Thousand USD | 56.85% |
| 2003 Q3 | 481 Thousand USD | 324.77% |
| 2003 Q4 | 814 Thousand USD | 69.23% |
| 2002 Q2 | -2.53 Million USD | -38.93% |
| 2002 FY | -10.17 Million USD | -439.58% |
| 2002 Q4 | -3.74 Million USD | -80.35% |
| 2002 Q1 | -1.82 Million USD | -336.69% |
| 2002 Q3 | -2.07 Million USD | 17.94% |
| 2001 Q2 | -517 Thousand USD | 35.86% |
| 2001 Q3 | -145 Thousand USD | 71.95% |
| 2001 Q4 | -417 Thousand USD | -187.59% |
| 2001 FY | -1.88 Million USD | 67.95% |
| 2001 Q1 | -806 Thousand USD | 13.24% |
| 2000 Q2 | -1.76 Million USD | 3.98% |
| 2000 Q4 | -929 Thousand USD | 31.34% |
| 2000 FY | -5.88 Million USD | 31.41% |
| 2000 Q1 | -1.83 Million USD | 8.58% |
| 2000 Q3 | -1.35 Million USD | 23.26% |
| 1999 Q4 | -2 Million USD | -0.91% |
| 1999 Q3 | -1.99 Million USD | 5.23% |
| 1999 Q1 | -2.5 Million USD | 16.67% |
| 1999 FY | -8.57 Million USD | 45.73% |
| 1999 Q2 | -2.1 Million USD | 16.0% |
| 1998 Q2 | -3.4 Million USD | 49.25% |
| 1998 Q4 | -3 Million USD | -3.45% |
| 1998 Q3 | -2.9 Million USD | 14.71% |
| 1998 Q1 | -6.7 Million USD | -42.55% |
| 1998 FY | -15.8 Million USD | -14.49% |
| 1997 Q1 | -2.3 Million USD | 32.35% |
| 1997 Q3 | -4.2 Million USD | -68.0% |
| 1997 Q4 | -4.7 Million USD | -11.9% |
| 1997 FY | -13.8 Million USD | -38.0% |
| 1997 Q2 | -2.5 Million USD | -8.7% |
| 1996 Q3 | -2.2 Million USD | -4.76% |
| 1996 Q4 | -3.4 Million USD | -54.55% |
| 1996 FY | -10 Million USD | -28.21% |
| 1996 Q1 | -2.2 Million USD | 72.84% |
| 1996 Q2 | -2.1 Million USD | 4.55% |
| 1995 FY | -7.8 Million USD | -34.48% |
| 1995 Q3 | 100 Thousand USD | 0.0% |
| 1995 Q1 | 100 Thousand USD | 101.64% |
| 1995 Q2 | 100 Thousand USD | 0.0% |
| 1995 Q4 | -8.1 Million USD | -8200.0% |
| 1994 Q2 | 100 Thousand USD | 0.0% |
| 1994 Q4 | -6.1 Million USD | -6200.0% |
| 1994 FY | -5.8 Million USD | 0.0% |
| 1994 Q3 | 100 Thousand USD | 0.0% |
| 1994 Q1 | 100 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | -2426.523% |
| IR-Med Inc. | -4.91 Million USD | -41.112% |
| Polarean Imaging plc | -12.55 Million USD | 44.808% |
| Medical Supply International USA, Inc. | 438.18 Thousand USD | 1681.542% |
| Avitar, Inc. | 2.73 Million USD | 353.585% |
| AVITA Medical, Inc. | -40.4 Million USD | 82.847% |
| Manhattan Scientifics, Inc. | -703 Thousand USD | -885.775% |
| Össur hf. | 87.46 Million USD | 107.924% |
| Zecotek Photonics Inc. | -3.65 Million USD | -89.511% |
| QHSLab, Inc. | -240.15 Thousand USD | -2785.6% |
| Wellstar International, Inc. | -1.79 Million USD | -286.138% |
| Össur hf. | 87.46 Million USD | 107.924% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 2.08 Million USD | 433.013% |
| Escalon Medical Corp. | -104.47 Thousand USD | -6533.102% |
| Aurora Spine Corporation | -446.19 Thousand USD | -1453.129% |
| BrainsWay Ltd. | -4.92 Million USD | -40.654% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.45 Million USD | 26.738% |
| Hamilton Thorne Ltd. | 277.99 Thousand USD | 2592.833% |
| Vivos Inc. | -2.79 Million USD | -148.107% |
| MicroPort Scientific Corporation | -516.16 Million USD | 98.657% |
| Kelyniam Global, Inc. | -239.16 Thousand USD | -2797.569% |
| REMSleep Holdings, Inc. | -1.77 Million USD | -291.163% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -1728.95% |
| Nanomix Corporation | -8.43 Million USD | 17.863% |
| Theraclion SA | -3.48 Million USD | -99.086% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.02 Thousand USD | -880.159% |
| Positron Corporation | -1.36 Million USD | -409.278% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.06 Million USD | -235.603% |
| Lombard Medical, Inc. | -29.33 Million USD | 76.376% |
| ALR Technologies Inc. | -2.94 Million USD | -135.209% |
| Stratec SE | 25.26 Million USD | 127.426% |
| Vycor Medical, Inc. | 40.19 Thousand USD | 17342.666% |
| Heart Tronics, Inc. | 14.46 Million USD | 147.925% |
| Nu-Med Plus, Inc. | -120.52 Thousand USD | -5649.797% |
| Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | 66.57% |
| SANUWAVE Health, Inc. | -540 Thousand USD | -1183.333% |
| VMS Rehab Systems, Inc. | -68.66 USD | -10093112.933% |
| Guided Therapeutics, Inc. | -3.45 Million USD | -100.463% |
| Ingen Technologies, Inc. | -1.61 Million USD | -329.463% |
| Odyssey Group International, Inc. | 14.26 Million USD | 148.594% |
| United American Healthcare Corporation | -67 Thousand USD | -10243.284% |
| ECGI Holdings, Inc. | -407.48 Thousand USD | -1600.697% |
| Capital Group Holdings, Inc. | -634.68 Thousand USD | -991.875% |
| ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | -1052.079% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.26 Million USD | -448.549% |
| Nexeon MedSystems Inc. | -6.26 Million USD | -10.615% |
| SS Innovations International, Inc. | -20.66 Million USD | 66.471% |
| Qualis Innovations, Inc. | -230.24 Thousand USD | -2909.89% |
| Smith & Nephew plc | 425 Million USD | 101.631% |
| NIOX Group Plc | 4.6 Million USD | 250.652% |
| Fuse Medical, Inc. | 383.82 Thousand USD | 1905.534% |
| Broncus Holding Corporation | -33.22 Million USD | 79.14% |
| Brain Scientific Inc. | -9.6 Million USD | 27.876% |
| Pressure BioSciences, Inc. | -9.5 Million USD | 27.078% |
| Health Logic Interactive Inc. | -60.69 Thousand USD | -11316.992% |